Malmö, November 4th, 2024 Obesity has emerged as one of the largest and most urgent health challenges worldwide, affecting over 650 million adults and contributing to life-threatening conditions such as heart disease, diabetes, and stroke.
In response to this challenge, the newest GLP-1 medications have proven effective in aiding weight loss, and the demand for these treatments has surged. Despite their efficacy, however, patients often struggle with long-term adherence and maintaining their weight loss goals.
Yazen addresses this critical gap by offering an integrated solution that goes beyond medication to support patients in achieving lasting results.
A holistic approach to sustainable weight loss
Yazen’s digital B2C platform provides users with personalized weight loss programs that combine GLP-1 therapy with lifestyle interventions targeting the root causes of obesity. Health professionals including coaches, doctors, dieticians and psychotherapists are equipped with an AI-powered interface to enhance care delivery, ensuring an efficient and seamless experience for both patients and providers.
Strong and sustainable growth
Since launching 2 years ago in Sweden, Yazen has grown rapidly, boasting a customer base of 20,000 active users and an ARR exceeding €15 million as of Q3 2024. Yazen has achieved a remarkable user retention rate of 70% after 12 months, demonstrating the effectiveness of its program.
Aiming for global expansion
To further accelerate growth, Yazen raised an oversubscribed €19.5 million Series A round. yabeo Venture Tech participated alongside other new investors Evli Growth Partners (Finland), Helsana HealthInvest (Switzerland) and Almaz Capital (Germany). The capital should enable Yazen to expand internationally across Europe, solidifying their position as a leader in the digital weight loss industry.

About Yazen
Founded by health care professionals in Sweden in 2021, Yazen is pioneering a revolutionary approach to obesity treatment through digital healthcare. Combining groundbreaking GLP-1 weight loss medications with comprehensive lifestyle guidance, Yazen offers a holistic, data-driven solution. With over 20,000 active users who have collectively lost 200+ tons, Yazen stands out in treating the global obesity epidemic. Its innovative model provides personalised obesity programmes through an advanced yet user-friendly app, enhancing access to specialist care including doctors, coaches, dietitians, psychologists and trainers.